INB-300

N/A

Report date: 2024/04/17 18:03:08

Base Information

Drug NameINB-300

Drug Alias NameINB-300DeltEx DRI CAR-T INB-300CAR γδT Cell Therapy INB-300

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionImmunologic cytotoxicityT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsSolid tumoursGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIN8BIO Inc

China Registration ClassN/A

Develop Information

Active CompaniesIN8BIO Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A